AI Science Tracker
EN

Predicting response to non-selective beta-blockers with liver-spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices

Affiliation not stated in the reviewed material · 25 Apr 2024 · medicine

Discovery

Predicting response to non-selective beta-blockers with liver-spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices

Source check: Source checked. Not independent scientific confirmation.

Finding: A prospective study used LASSO logistic regression to select three-month percentage changes in spleen stiffness, liver stiffness and heart rate for predicting 12-month NSBB response in cirrhosis with high-risk varices. The combined model reached AUROC 0.96 in derivation and 0.91 in a separate geographic validation cohort. This supports a bounded prediction result, not proof of improved care or HVPG-confirmed response. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: LASSO

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Tenfold-CV LASSO logistic regression selects three-month percentage reductions in spleen stiffness, liver stiffness and heart rate; a combined logistic model estimates clinical NSBB response probability.
Test and result
A prospective study used LASSO logistic regression to select three-month percentage changes in spleen stiffness, liver stiffness and heart rate for predicting 12-month NSBB response in cirrhosis with high-risk varices. The combined model reached AUROC 0.96 in derivation and 0.91 in a separate geographic validation cohort. This supports a bounded prediction result, not proof of improved care or HVPG-confirmed response.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study. Organization affiliation was not available in retrieved Crossref metadata. Organization affiliation was not stated in the source material reviewed. Affiliation was not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12003444/ · https://pubmed.ncbi.nlm.nih.gov/38664292/ · https://link.springer.com/article/10.1007/s12072-024-10649-7

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.